JAZZ Jazz Pharmaceuticals plc - Ordinary Shares
$252.44
मूल्य · अग 18, 2026
मौलिकता इस प्रकार है अग 3, 2026
52W रेंज
$118–$265
91% of range
विश्लेषक रेटिंग
BUY
26 analysts
मूल्य लक्ष्य
$281
+11% upside
P/E (TTM)
-29.1
ROE
—
शुद्ध लाभ मार्जिन
—
Jazz Pharmaceuticals plc - Ordinary Shares के बारे में विकिपीडिया से कंपनी का अवलोकन
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
और पढ़ें
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Company history and acquisitions
2010–2019
On 18 February 2010, the FDA accepted a new drug application for JZP-6 (Sodium oxybate) for the treatment of Fibromyalgia. In the following December, a new patent was issued for Sodium Oxybate.
On September 19, 2011, Jazz Pharmaceuticals merged with Irish Azur Pharma plc to form Jazz Pharmaceuticals plc. The Azur Pharma seat in Dublin became the headquarters of the combined company. Azur Pharma had been marketing specialty pharmaceutical products in the central nervous system (CNS) and women's health areas with US operations in Philadelphia.
On 26 April 2012, the company acquired EUSA Pharma for $650 million (plus $50 million in milestone payments). In September, the company sold its Women's Health business to Meda for $95 million. In December, the company began clinical trial of intravenous Erwinaze in patients with Acute Lymphoblastic Leukemia.
In January 2014, the company announced it would acquire the rare disease drug developer Gentium SpA and its lead product Defitelio for $1 billion.
In May 2016, the company announced it would acquire Alizé Pharma II for $20.5 million. At the end of the same month, the company announced its then largest acquisition, with the purchase of Celator Pharmaceuticals for $1.5 billion. As a result, Jazz obtained the rights to breakthrough therapy Vyxeos (liposomal daunorubicin and cytarabine) for treatment of acute myeloid leukemia.
In August 2019, the company announced it would acquire Cavion Inc. for up to $310 million.
2020–present
In January 2021, Jazz announced it would acquire cannabis-focused medicinal drug company GW Pharmaceuticals for US$7.2 billion. This acquisition added the medication Epidiolex (cannabidiol), developed to treat severe epilepsy syndromes, to the company's portfolio.
In November 2025, Jazz Pharmaceuticals announced positive results from its Phase 3 trial for its cancer drug, Ziihera, a potential treatment for advanced gastroesophageal cancer.
Acquisition history
The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors:
== References ==
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
JAZZ स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$252.44
मार्केट कैप
—
P/E (TTM)
-29.1
EPS (TTM)
$-5.84
राजस्व (TTM)
$4.27B
लाभांश प्रतिफल
—
ROE
—
D/E ऋण/इक्विटी
—
52W रेंज
$118 – $265
JAZZ स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
Configure
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व और शुद्ध आय
$4.27B
2016-12-31
→
2025-12-31
EPS
$-5.84
2016-12-31
→
2025-12-31
फ्री कैश फ्लो
—
मार्जिन
—
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
मेट्रिक
5Y रुझान
JAZZ
सहकर्मी माध्यिका
P/E (TTM)
-29.1
530.6
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
मेट्रिक
5Y रुझान
JAZZ
सहकर्मी माध्यिका
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
मेट्रिक
5Y रुझान
JAZZ
सहकर्मी माध्यिका
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
मेट्रिक
5Y रुझान
JAZZ
सहकर्मी माध्यिका
Revenue YoY (राजस्व YoY)
4.9%
—
Revenue CAGR 3Y (राजस्व CAGR 3Y)
5.3%
—
Revenue CAGR 5Y (राजस्व CAGR 5Y)
12.5%
—
EPS YoY
41.8%
—
Net Income YoY (शुद्ध आय YoY)
35.0%
—
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
मेट्रिक
5Y रुझान
JAZZ
सहकर्मी माध्यिका
JAZZ विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
खरीदें
26 विश्लेषक
- मजबूत खरीद 7 26.9%
- खरीदें 17 65.4%
- होल्ड 2 7.7%
- बेचें 0 0.0%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
20 विश्लेषक · 2026-08-15
मध्यिका
$285.00
अभी
$252.44
निम्न
$196.00
उच्च
$315.00
मध्यिका लक्ष्य
$285.00
+12.9%
माध्य लक्ष्य
$281.10
+11.4%
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
-0.06%
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $5.71 | $6.30 | -0.59% |
| 31 मार्च 2026 | $6.34 | $4.66 | 1.7% |
| 31 दिसमबर 2025 | $6.64 | $6.65 | -0.01% |
| 30 सितमबर 2025 | $8.13 | $6.04 | 2.1% |
| 30 जून 2025 | $-8.25 | $-7.76 | -0.49% |
| 31 मार्च 2025 | $1.68 | $4.75 | -3.1% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| JAZZ | — | -29.1 | 4.9% | — | — | — |
| GHRS | — | — | — | — | — | — |
| PRGO | $1.92B | -1.4 | -2.8% | -33.5% | -38.5% | 35.1% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 14
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| R&D Expense | · | · | · | · | · | · | $300M | $227M | $198M | $162M | $135M | $85M | |
| SG&A Expense | $1.81B | $1.39B | $1.34B | $1.42B | $1.45B | $854M | $737M | $684M | $544M | $503M | $449M | $406M | |
| Operating Expenses | $4.70B | $3.35B | $3.26B | $3.72B | $2.92B | $1.99B | $1.63B | $1.28B | $1.09B | $896M | $817M | $977M | |
| Operating Income | $-430M | $717M | $579M | $-66M | $170M | $378M | $532M | $615M | $529M | $592M | $508M | $196M | |
| Interest Income | $86M | $106M | $65M | $12M | $2M | $11M | $20M | $17M | $4M | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $1M | $9M | |
| Pretax Income | $-628M | $470M | $298M | $-373M | $-113M | $275M | $454M | $529M | $441M | $532M | $436M | $152M | |
| Income Tax | $-272M | $-91M | $-120M | $-159M | $216M | $34M | $-73M | $80M | $-48M | $135M | $106M | $94M | |
| Net Income | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| EPS (Basic) | $-5.84 | $9.06 | $6.55 | $-3.58 | $-5.52 | $4.28 | $9.22 | $7.45 | $8.13 | $6.56 | $5.38 | $0.98 | |
| EPS (Diluted) | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 | $4.22 | $9.09 | $7.30 | $7.96 | $6.41 | $5.23 | $0.93 | |
| Shares (Basic) | 60,981,000 | 61,838,000 | 63,291,000 | 62,539,000 | 59,694,000 | 55,712,000 | 56,749,000 | 59,976,000 | 60,018,000 | 60,500,000 | 61,232,000 | 59,746,000 | |
| Shares (Diluted) | 60,981,000 | 66,007,000 | 72,066,000 | 62,539,000 | 59,694,000 | 56,517,000 | 57,550,000 | 61,221,000 | 61,317,000 | 61,870,000 | 63,036,000 | 62,614,000 |
बैलेंस शीट 26
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.39B | $2.41B | $1.51B | $881M | $591M | $1.06B | $637M | $310M | $386M | $366M | $989M | $684M | |
| Receivables | $831M | $717M | $706M | $651M | $563M | $396M | $356M | $264M | $224M | $234M | $210M | $186M | |
| Inventory | $417M | $480M | $597M | $714M | $1.07B | $95M | $79M | $53M | $43M | $34M | $19M | $30M | |
| Prepaid Expense | $152M | $177M | $185M | $92M | $131M | $62M | $39M | $25M | $23M | $25M | $21M | $13M | |
| Other Current Assets | $324M | $262M | $321M | $267M | $252M | $152M | $79M | $68M | $77M | $29M | $19M | $21M | |
| Current Assets | $4.17B | $4.63B | $3.44B | $2.61B | $2.61B | $2.84B | $1.63B | $1.23B | $968M | $748M | $1.26B | $1.02B | |
| PP&E (Net) | · | · | · | · | · | $128M | $132M | $200M | $170M | $107M | $86M | $58M | |
| PP&E (Gross) | · | · | · | · | · | $196M | $187M | $250M | $211M | $140M | $109M | $74M | |
| Accum. Depreciation | · | · | · | · | · | $68M | $55M | $50M | $41M | $32M | $24M | $15M | |
| Goodwill | $1.83B | $1.72B | $1.75B | $1.69B | $1.83B | $958M | $920M | $928M | $948M | $894M | $657M | $703M | |
| Intangibles | $4.43B | $4.76B | $5.42B | $5.79B | $7.15B | $2.20B | $2.44B | $2.73B | $2.98B | $3.01B | $1.19B | $1.44B | |
| Other Non-current Assets | $99M | $114M | $67M | $55M | $41M | $26M | $48M | $43M | $16M | $14M | $9M | $16M | |
| Total Assets | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Accounts Payable | $122M | $78M | $103M | $91M | $100M | $27M | $46M | $41M | $24M | $22M | $22M | $25M | |
| Accrued Liabilities | $1.03B | $911M | $794M | $803M | $666M | $353M | $270M | $265M | $199M | $193M | $164M | $164M | |
| Current Liabilities | $2.24B | $1.04B | $1.54B | $933M | $809M | $654M | $364M | $345M | $294M | $257M | $227M | $217M | |
| Capital Leases | $51M | $39M | $59M | $72M | $87M | $140M | $151M | $0 | · | · | · | · | |
| Deferred Tax | $594M | $677M | $848M | $944M | $1.30B | $130M | $224M | $309M | $383M | $557M | $283M | $375M | |
| Other Non-current Liabilities | $124M | $87M | $105M | $107M | $117M | $101M | $109M | $219M | $177M | $113M | $69M | $38M | |
| Long-term Debt | $5.36B | $6.11B | $5.71B | $5.72B | $6.05B | $2.09B | $1.61B | $1.60B | $1.58B | $2.03B | $1.19B | $1.34B | |
| Common Stock | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Retained Earnings | $646M | $1.13B | $879M | $734M | $830M | $1.16B | $1.07B | $841M | $918M | $529M | $303M | $35M | |
| AOCI | $-569M | $-948M | $-842M | $-1.13B | $-400M | $-134M | $-223M | $-198M | $-141M | $-317M | $-267M | $-122M | |
| Stockholders' Equity | $4.32B | $4.09B | $3.74B | $3.09B | $3.97B | $3.66B | $3.11B | $2.76B | $2.71B | $1.88B | $1.71B | $1.37B | |
| Liabilities + Equity | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Shares Outstanding | 61,400,000 | 60,600,000 | 62,255,000 | 63,214,000 | 61,633,000 | 56,171,000 | 56,140,000 | 57,704,000 | 58,898,000 | 59,820,000 | 61,305,000 | 60,643,000 |
नकदी प्रवाह 12
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $33M | $30M | $30M | $27M | $19M | $15M | $15M | $13M | $12M | $10M | · | |
| Stock-based Comp | $291M | $248M | $227M | $222M | $189M | $121M | $111M | $102M | $107M | $99M | $92M | $70M | |
| Deferred Tax | $-445M | $-208M | $-260M | $-292M | $69M | $-137M | $-237M | $-89M | $-226M | $-41M | $-68M | $-49M | |
| Amort. of Intangibles | $655M | $627M | $608M | $599M | $526M | $260M | $355M | $201M | $152M | $102M | $98M | $127M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Operating Cash Flow | $1.36B | $1.40B | $1.09B | $1.27B | $779M | $900M | $776M | $799M | $693M | $592M | $532M | $408M | |
| CapEx | $59M | $38M | $24M | $29M | $28M | $15M | $40M | $20M | $29M | $10M | $36M | $36M | |
| Investing Cash Flow | $-1.51B | $-508M | $-163M | $-446M | $-5.21B | $-1.01B | $-155M | $-394M | $-269M | $-1.75B | $-2M | $-1.07B | |
| Stock Repurchased | $125M | $311M | $270M | $54.0K | $0 | $147M | $301M | $524M | $99M | $278M | $62M | $42M | |
| Financing Cash Flow | $-873M | $21M | $-305M | $-529M | $3.97B | $528M | $-294M | $-479M | $-409M | $541M | $-214M | $711M | |
| Net Change in Cash | $-1.02B | $907M | $625M | $290M | $-466M | $420M | $328M | $-76M | $20M | $-623M | $305M | $48M | |
| Taxes Paid | $122M | $115M | $178M | · | · | · | · | · | · | · | · | · |
विकास दरें 7
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.9% | 6.1% | 4.8% | 18.3% | 30.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.3% | 9.6% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 12.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 41.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | 13.1% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 35.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | 20.2% | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| Net Income TTM | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| P/E | -29.1 | 14.2 | 20.2 | -44.5 | -23.1 | 39.1 | 16.4 | 17.0 | 16.9 | 17.0 | 26.9 | 176.1 | |
| P / Tangible Book | · | · | · | · | · | 18.3 | · | · | · | · | · | · | |
| Earnings Yield | -3.4% | 7.0% | 5.0% | -2.2% | -4.3% | 2.6% | 6.1% | 5.9% | 5.9% | 5.9% | 3.7% | 0.57% |
आय विवरण 13
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.07B | $1.20B | $1.13B | $1.05B | $898M | $1.09B | $1.05B | $1.02B | $902M | $1.01B | $972M | $957M | $893M | $972M | $941M | |
| SG&A Expense | $389M | $353M | $406M | $531M | $358M | $514M | $369M | $326M | $339M | $352M | $396M | $308M | $341M | $298M | $383M | $358M | |
| Operating Expenses | $960M | $732M | $943M | $1.07B | $1.73B | $954M | $897M | $795M | $824M | $836M | $889M | $800M | $800M | $767M | $1.24B | $916M | |
| Operating Income | $248M | $337M | $255M | $58M | $-686M | $-56M | $191M | $260M | $199M | $66M | $122M | $172M | $158M | $126M | $-263M | $25M | |
| Interest Income | $25M | $23M | $20M | $19M | $19M | $28M | $32M | $26M | $25M | $23M | $21M | $19M | $15M | $11M | $7M | $4M | |
| Pretax Income | $211M | $299M | $208M | $9M | $-736M | $-110M | $133M | $201M | $138M | $-2M | $62M | $100M | $82M | $55M | $-340M | $-60M | |
| Income Tax | $18M | $6M | $5M | $-242M | $-17M | $-18M | $-58M | $-15M | $-31M | $12M | $-33M | $-47M | $-24M | $-15M | $-100M | $-43M | |
| Net Income | $193M | $293M | $203M | $251M | $-718M | $-92M | $191M | $215M | $169M | $-15M | $94M | $147M | $104M | $69M | $-241M | $-20M | |
| EPS (Basic) | $3.05 | $4.73 | $3.28 | $4.14 | $-11.74 | $-1.52 | $3.11 | $3.50 | $2.68 | $-0.23 | $1.50 | $2.33 | $1.63 | $1.09 | $-3.86 | $-0.31 | |
| EPS (Diluted) | $2.78 | $4.43 | $3.34 | $4.08 | $-11.74 | $-1.52 | $2.97 | $3.42 | $2.49 | $-0.23 | $1.40 | $2.14 | $1.52 | $1.04 | $-3.85 | $-0.31 | |
| Shares (Basic) | 63,200,000 | 61,900,000 | -121,888,000 | 60,696,000 | 61,200,000 | 61,000,000 | -124,995,000 | 61,414,000 | 62,882,000 | 62,537,000 | -127,308,000 | 63,114,000 | 63,991,000 | 63,494,000 | -124,547,000 | 62,785,000 | |
| Shares (Diluted) | 69,400,000 | 66,100,000 | -122,798,000 | 61,606,000 | 61,200,000 | 61,000,000 | -129,329,000 | 63,174,000 | 69,625,000 | 62,537,000 | -146,538,000 | 71,293,000 | 73,540,000 | 73,771,000 | -126,584,000 | 62,785,000 | |
| EBITDA | $248M | $337M | · | $58M | $-686M | $-56M | · | $260M | $199M | $66M | · | $172M | $158M | $126M | · | $25M |
बैलेंस शीट 24
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.62B | $1.84B | $1.39B | $1.33B | $1.19B | $1.86B | $2.41B | $2.22B | $1.36B | $1.44B | · | $1.34B | $1.28B | $1.17B | · | $839M | |
| Receivables | $881M | $836M | $831M | $764M | $714M | $653M | $717M | $724M | $698M | $707M | · | $628M | $610M | $624M | · | $601M | |
| Inventory | $443M | $438M | $417M | $483M | $505M | $493M | $480M | $539M | $543M | $577M | · | $612M | $657M | $675M | · | $728M | |
| Prepaid Expense | $200M | $150M | $152M | $147M | $164M | $150M | $177M | $155M | $134M | $123M | · | $110M | $107M | $73M | · | $93M | |
| Other Current Assets | $244M | $285M | $324M | $315M | $298M | $260M | $262M | $354M | $326M | $315M | · | $310M | $272M | $245M | · | $250M | |
| Current Assets | $3.97B | $4.58B | $4.17B | $3.76B | $3.35B | $4.13B | $4.63B | $4.39B | $3.68B | $3.54B | · | $3.25B | $3.01B | $2.78B | · | $2.57B | |
| Goodwill | $1.80B | $1.80B | $1.83B | $1.83B | $1.84B | $1.76B | $1.72B | $1.80B | $1.74B | $1.74B | · | $1.71B | $1.74B | $1.72B | · | $1.59B | |
| Intangibles | $4.03B | $4.20B | $4.43B | $4.57B | $4.77B | $4.72B | $4.76B | $5.14B | $5.08B | $5.24B | · | $5.42B | $5.71B | $5.76B | · | $5.57B | |
| Other Non-current Assets | $86M | $95M | $99M | $103M | $121M | $117M | $114M | $75M | $71M | $71M | · | $76M | $66M | $64M | · | $35M | |
| Total Assets | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Accounts Payable | $128M | $100M | $122M | $152M | $89M | $96M | $78M | $85M | $97M | $81M | · | $110M | $98M | $125M | · | $102M | |
| Accrued Liabilities | $1.03B | $1.02B | $1.03B | $1.00B | $875M | $1.06B | $911M | $859M | $801M | $827M | · | $770M | $748M | $712M | · | $668M | |
| Current Liabilities | $2.23B | $2.25B | $2.24B | $2.27B | $2.07B | $1.22B | $1.04B | $1.03B | $1.56B | $1.56B | · | $1.57B | $945M | $909M | · | $813M | |
| Capital Leases | $44M | $47M | $51M | $53M | $55M | $39M | $39M | $71M | $68M | $56M | · | $62M | $66M | $72M | · | $73M | |
| Deferred Tax | $529M | $548M | $594M | $629M | $682M | $671M | $677M | $792M | $775M | $810M | · | $841M | $911M | $932M | · | $934M | |
| Other Non-current Liabilities | $141M | $162M | $125M | $109M | $94M | $91M | $87M | $111M | $99M | $97M | · | $127M | $127M | $109M | · | $124M | |
| Long-term Debt | $4.35B | $5.35B | $5.36B | $5.36B | $5.36B | $5.37B | $6.11B | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Total Debt | $4.35B | $5.35B | · | $5.36B | $5.36B | $5.37B | · | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Common Stock | $0 | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $1.13B | $939M | $646M | $443M | $191M | $1.03B | $1.13B | $936M | $871M | $864M | · | $884M | $812M | $803M | · | $974M | |
| AOCI | $-662M | $-651M | $-569M | $-570M | $-486M | $-786M | $-948M | $-603M | $-888M | $-882M | · | $-1.04B | $-867M | $-980M | · | $-1.62B | |
| Stockholders' Equity | $4.80B | $4.53B | $4.32B | $3.96B | $3.71B | $4.17B | $4.09B | $4.17B | $3.76B | $3.70B | $3.74B | $3.49B | $3.53B | $3.34B | $3.09B | $2.75B | |
| Liabilities + Equity | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Shares Outstanding | 64,800,000 | 62,700,000 | 61,435,000 | 60,740,000 | 60,640,000 | 61,623,000 | 60,631,000 | 60,443,000 | 61,745,000 | 63,028,000 | 62,255,000 | 62,945,000 | · | · | 63,214,000 | · |
नकदी प्रवाह 10
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $73M | $74M | $71M | $88M | $65M | $68M | $70M | $60M | $57M | $61M | $53M | $56M | $61M | $56M | $62M | $57M | |
| Deferred Tax | $-39M | $-66M | $-63M | $-271M | $-66M | $-44M | $-2M | $-64M | $-75M | $-66M | $-36M | $-79M | $-79M | $-66M | $-145M | $-65M | |
| Amort. of Intangibles | $170M | $172M | $170M | $168M | $162M | $154M | $159M | $157M | $155M | $156M | $152M | $155M | $152M | $150M | $137M | $141M | |
| Operating Cash Flow | $416M | $408M | $363M | $475M | $89M | $430M | $399M | $399M | $331M | $267M | $167M | $307M | $297M | $321M | $342M | $418M | |
| CapEx | $18M | $20M | $17M | $15M | $13M | $14M | $13M | $11M | $7M | $7M | $10M | $4M | $6M | $4M | $9M | $-5M | |
| Investing Cash Flow | $355M | $123M | $-372M | $-328M | $-641M | $-169M | $-193M | $214M | $-257M | $-272M | $102M | $-174M | $-86M | $-5M | $-324M | $5M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $150M | · | · | $100M | $74M | · | · | $0 | $0 | |
| Financing Cash Flow | $-994M | $-78M | $75M | $-11M | $-125M | $-814M | $-8M | $246M | $-161M | $-57M | $-100M | $-78M | $-97M | $-30M | $20M | $-289M | |
| Net Change in Cash | $-224M | $452M | $66M | $136M | $-672M | $-551M | $195M | $862M | $-88M | $-63M | $171M | $53M | $114M | $286M | $42M | $128M | |
| Free Cash Flow | · | $388M | · | · | · | $416M | · | · | · | $260M | · | · | · | $317M | · | · |
लाभप्रदता 7
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| Net Margin | 16.0% | 27.4% | · | 22.3% | -68.7% | -10.3% | · | 20.4% | 16.5% | -1.6% | · | 15.1% | 10.9% | 7.8% | · | -2.1% | |
| Pretax Margin | 17.5% | 28.0% | · | 0.80% | -70.3% | -12.2% | · | 19.0% | 13.5% | -0.18% | · | 10.2% | 8.5% | 6.2% | · | -6.4% | |
| EBITDA Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| ROA | 1.8% | 2.5% | · | 2.1% | -6.4% | -0.81% | · | 1.8% | 1.5% | -0.13% | · | 1.4% | 0.93% | 0.61% | · | -0.17% | |
| ROE | 4.5% | 6.7% | · | 6.2% | -19.2% | -2.4% | · | 5.6% | 4.6% | -0.42% | · | 4.7% | 3.1% | 2.0% | · | -0.59% | |
| ROIC | 2.5% | 3.3% | · | 17.2% | -7.4% | -0.49% | · | 2.7% | 2.6% | 5.8% | · | 2.8% | 2.2% | 1.8% | · | 0.08% |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.0 | · | 1.7 | 1.6 | 3.4 | · | 4.3 | 2.4 | 2.3 | · | 2.1 | 3.2 | 3.1 | · | 3.2 | |
| Quick Ratio | 1.1 | 1.2 | · | 0.9 | 0.9 | 2.1 | · | 2.9 | 1.3 | 1.4 | · | 1.2 | 2.0 | 2.0 | · | 1.8 | |
| Debt / Equity | 0.9 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.7 | · | 2.1 | |
| LT Debt / Equity | 0.7 | 1.0 | · | 1.1 | 1.2 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 2.1 |
दक्षता 2
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.3 | · | 1.6 | 1.6 | 1.4 | · | 1.6 | 1.6 | 1.5 | · | 1.7 |
मूल्यांकन (TTM) 13
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.45B | $4.14B | · | $4.12B | $4.02B | $3.88B | · | $3.95B | $3.86B | $3.72B | · | $3.76B | $3.72B | $3.58B | · | $3.53B | |
| Net Income TTM | $19M | $-266M | · | $-345M | $-427M | $276M | · | $516M | $405M | $306M | · | $301M | $189M | $86M | · | $-36M | |
| Market Cap | $15.61B | $11.85B | · | $8.01B | $6.44B | $7.65B | · | $6.73B | $6.59B | $7.59B | · | $8.15B | · | · | · | · | |
| Enterprise Value | $18.35B | $15.36B | · | $12.04B | $10.61B | $11.16B | · | $10.63B | $10.94B | $11.86B | · | $12.53B | · | · | · | · | |
| P/E | -535.5 | -39.8 | · | -22.9 | -14.4 | 29.8 | · | 14.2 | 18.0 | 26.9 | · | 29.5 | 44.3 | 111.7 | · | -225.9 | |
| P/S | 3.5 | 2.9 | · | 1.9 | 1.6 | 2.0 | · | 1.7 | 1.7 | 2.0 | · | 2.2 | · | · | · | · | |
| P/B | 3.3 | 2.6 | · | 2.0 | 1.7 | 1.8 | · | 1.6 | 1.8 | 2.1 | · | 2.3 | · | · | · | · | |
| P / Cash Flow | · | 29.0 | · | · | · | 17.8 | · | · | · | 28.4 | · | · | · | · | · | · | |
| P / FCF | · | 30.5 | · | · | · | 18.4 | · | · | · | 29.2 | · | · | · | · | · | · | |
| EV / EBITDA | 73.9 | 45.6 | · | 209.4 | -15.5 | -199.6 | · | 40.8 | 54.9 | 179.1 | · | 72.7 | · | · | · | · | |
| EV / FCF | · | 39.5 | · | · | · | 26.8 | · | · | · | 45.5 | · | · | · | · | · | · | |
| EV / Revenue | 4.1 | 3.7 | · | 2.9 | 2.6 | 2.9 | · | 2.7 | 2.8 | 3.2 | · | 3.3 | · | · | · | · | |
| Earnings Yield | -0.19% | -2.5% | · | -4.4% | -6.9% | 3.4% | · | 7.0% | 5.5% | 3.7% | · | 3.4% | 2.3% | 0.90% | · | -0.44% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B |
| शुद्ध आय | $-356M | $560M | $415M | $-224M | $-330M |
| तनुकरणित EPS | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
📊
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 690 फाइलर्स · $9.8B कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 143 (+46 पिछली तिमाही की तुलना में) | 56 (-21 पिछली तिमाही की तुलना में) | 220 (+20 पिछली तिमाही की तुलना में) | 190 (+12 पिछली तिमाही की तुलना में) | +4.4M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| FMR LLC | $846470147 | 3512762 | 8.60% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $731636247 | 3036213 | 7.43% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $657763761 | 2729650 | 6.68% | शेयर |
| Capital World Investors | $650043082 | 2697610 | 6.60% | शेयर |
| STATE STREET CORP | $481895662 | 1999816 | 4.89% | शेयर |
| FULLER & THALER ASSET MANAGEMENT, INC. | $394839917 | 1638544 | 4.01% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $390196222 | 1619274 | 3.96% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $297928728 | 1236065 | 3.03% | शेयर |
| AMERIPRISE FINANCIAL INC | $260580996 | 1081421 | 2.65% | शेयर |
| CITADEL ADVISORS LLC | $242578716 | 1006676 | 2.46% | शेयर |
| Swedbank AB | $233208837 | 967792 | 2.37% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $184072164 | 763880 | 1.87% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $165478678 | 686719 | 1.68% | शेयर |
| NORGES BANK | $158279458 | 656843 | 1.61% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $135442731 | 562073 | 1.38% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $129891746 | 539037 | 1.32% | शेयर |
| Allianz Asset Management GmbH | $122925785 | 510129 | 1.25% | शेयर |
| GMT Capital Corp | $109279895 | 453500 | 1.11% | शेयर |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $105278106 | 436893 | 1.07% | शेयर |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $103893734 | 431148 | 1.06% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $96439086 | 400212 | 0.98% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $95008929 | 394277 | 0.96% | शेयर |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $89279867 | 370502 | 0.91% | शेयर |
| Sofinnova Investments, Inc. | $88036221 | 365341 | 0.89% | शेयर |
| Polaris Capital Management, LLC | $79270937 | 328966 | 0.81% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $77695234 | 322427 | 0.79% | शेयर |
| Bank of New York Mellon Corp | $76961481 | 319382 | 0.78% | शेयर |
| GOLDENTREE ASSET MANAGEMENT LP | $70838675 | 294435 | 0.72% | शेयर |
| Qube Research & Technologies Ltd | $70056003 | 290725 | 0.71% | शेयर |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $66815854 | 277279 | 0.68% | शेयर |
| Quantinno Capital Management LP | $65906960 | 273506 | 0.67% | शेयर |
| Boston Trust Walden Corp | $64110068 | 266050 | 0.65% | शेयर |
| BANK OF AMERICA CORP /DE/ | $60589497 | 251440 | 0.62% | शेयर |
| Tri Locum Partners LP | $53427868 | 221720 | 0.54% | शेयर |
| Iron Triangle Partners LP | $49668900 | 292170 | 0.50% | शेयर |
| ARGENT CAPITAL MANAGEMENT LLC | $48211350 | 200072 | 0.49% | शेयर |
| GOLDMAN SACHS GROUP INC | $45527185 | 188933 | 0.46% | शेयर |
| PERCEPTIVE ADVISORS LLC | $40964900 | 170000 | 0.42% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $39434259 | 163648 | 0.40% | शेयर |
| RHUMBLINE ADVISERS | $39282382 | 163018 | 0.40% | शेयर |
| Holocene Advisors, LP | $38794001 | 160991 | 0.39% | शेयर |
| Saturn V Capital Management LP | $38781230 | 160938 | 0.39% | शेयर |
| PFM Health Sciences, LP | $38740265 | 160768 | 0.39% | शेयर |
| Retirement Systems of Alabama | $38473993 | 159663 | 0.39% | शेयर |
| Woodline Partners LP | $36165501 | 150083 | 0.37% | शेयर |
| LOOMIS SAYLES & CO L P | $35355338 | 146721 | 0.36% | शेयर |
| Pictet Asset Management Holding SA | $35115175 | 147599 | 0.36% | शेयर |
| PRINCIPAL FINANCIAL GROUP INC | $34163762 | 141776 | 0.35% | शेयर |
| STIFEL FINANCIAL CORP | $33583066 | 139365 | 0.34% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $33026625 | 137057 | 0.34% | शेयर |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $32383478 | 134388 | 0.33% | शेयर |
| California Public Employees Retirement System | $30759098 | 127647 | 0.31% | शेयर |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $30249134 | 160006 | 0.31% | शेयर |
| Robeco Institutional Asset Management B.V. | $28340967 | 117612 | 0.29% | शेयर |
| Gotham Asset Management, LLC | $26992014 | 112014 | 0.27% | शेयर |
| Aristotle Capital Management, LLC | $26915626 | 111697 | 0.27% | शेयर |
| Swiss National Bank | $26771767 | 111100 | 0.27% | शेयर |
| STOREBRAND ASSET MANAGEMENT AS | $26309828 | 109183 | 0.27% | शेयर |
| CANADA PENSION PLAN INVESTMENT BOARD | $25928372 | 107600 | 0.26% | शेयर |
| PANAGORA ASSET MANAGEMENT INC | $25286187 | 104935 | 0.26% | शेयर |
| BlackRock, Inc. | $23889284 | 99138 | 0.24% | शेयर |
| Perpetual Ltd | $23733376 | 98491 | 0.24% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $23658917 | 98182 | 0.24% | शेयर |
| MORGAN STANLEY | $23519795 | 97604 | 0.24% | शेयर |
| Man Group plc | $23299389 | 96690 | 0.24% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22868053 | 94900 | 0.23% | पुट ऑप्शन |
| ENVESTNET ASSET MANAGEMENT INC | $22061835 | 91554 | 0.22% | शेयर |
| Rhenman & Partners Asset Management AB | $21070417 | 87440 | 0.21% | शेयर |
| Aberdeen Group plc | $20146538 | 83606 | 0.20% | शेयर |
| Amundi | $19114464 | 79323 | 0.19% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18916145 | 78500 | 0.19% | कॉल ऑप्शन |
| Schonfeld Strategic Advisors LLC | $18620232 | 77272 | 0.19% | शेयर |
| FIRST TRUST ADVISORS LP | $18149860 | 75320 | 0.18% | शेयर |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $17765513 | 73725 | 0.18% | शेयर |
| LAZARD ASSET MANAGEMENT LLC | $16768620 | 69588 | 0.17% | शेयर |
| Longaeva Partners L.P. | $16576808 | 68792 | 0.17% | शेयर |
| Simplify Asset Management Inc. | $16520903 | 68560 | 0.17% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $16497448 | 87265 | 0.17% | शेयर |
| Distillate Capital Partners LLC | $16167159 | 67092 | 0.16% | शेयर |
| SEB Asset Management AB | $15890255 | 65943 | 0.16% | शेयर |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15380484 | 64700 | 0.16% | शेयर |
| SEI INVESTMENTS CO | $14931224 | 61963 | 0.15% | शेयर |
| Illinois Municipal Retirement Fund | $14911947 | 61883 | 0.15% | शेयर |
| Tweedy, Browne Co LLC | $14494105 | 60149 | 0.15% | शेयर |
| MARTINGALE ASSET MANAGEMENT L P | $14335788 | 59492 | 0.15% | शेयर |
| DeepCurrents Investment Group LLC | $14132168 | 58647 | 0.14% | शेयर |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $13348774 | 55396 | 0.14% | शेयर |
| VANGUARD ASSET MANAGEMENT, Ltd | $12952138 | 53750 | 0.13% | शेयर |
| ExodusPoint Capital Management, LP | $12819845 | 53201 | 0.13% | शेयर |
| Squarepoint Ops LLC | $12807074 | 53148 | 0.13% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12034356 | 63657 | 0.12% | शेयर |
| ALGERT GLOBAL LLC | $11749697 | 48760 | 0.12% | शेयर |
| CASTLEARK MANAGEMENT LLC | $11306312 | 46920 | 0.11% | शेयर |
| CITADEL ADVISORS LLC | $11253299 | 46700 | 0.11% | कॉल ऑप्शन |
| RENAISSANCE GROUP LLC | $11221601 | 46568 | 0.11% | शेयर |
| Nuveen, LLC | $11184623 | 46415 | 0.11% | शेयर |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $10859795 | 45067 | 0.11% | शेयर |
| Foundry Partners, LLC | $10730160 | 86429 | 0.11% | शेयर |
| Legal & General Group Plc | $10402916 | 43171 | 0.11% | शेयर |
| DEAN INVESTMENT ASSOCIATES, LLC | $10273274 | 42633 | 0.10% | शेयर |
कंपनी के अंदरूनी सूत्र 50 इनसाइडर्स · 4 अधिकारी · 4 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Renee D Gala | President & CEO | 30 जून 2026 F | 147361 | 0 | 0 | $0 |
| Philip L Johnson | EVP & Chief Financial Officer | 30 जून 2026 F | 56431 | 0 | 0 | $0 |
| Neena M Patil | EVP & Chief Legal Officer | 30 जून 2026 F | 48871 | 0 | 2 | $-560664 |
| Robert Iannone | EVP, Global Head of R&D & CMO | 30 जून 2026 F | 85107 | 0 | 0 | $0 |
| Bryan C Cressey | निदेशक | 9 मार्च 2012 S | 27631 | 0 | 0 | $0 |
| Zilkha M Nathaniel | निदेशक | 10 मार्च 2011 A | — | 0 | 0 | $0 |
| Alexander E Albert | निदेशक | 15 अगस्त 2008 A | — | 0 | 0 | $0 |
| Patel Jaimin | निदेशक | 15 अगस्त 2007 A | — | 0 | 0 | $0 |
| Patrick Kennedy | — | 5 अगस्त 2026 A | 8307 | 0 | 0 | $0 |
| Samantha Pearce | — | 5 अगस्त 2026 F | 47131 | 0 | 1 | $-1625977 |
| Mark Douglas Smith | — | 5 अगस्त 2026 A | 11285 | 0 | 1 | $-266746 |
| Jennifer E. Cook | — | 5 अगस्त 2026 A | 12442 | 0 | 0 | $0 |
| Laura Hamill | — | 5 अगस्त 2026 A | 8538 | 0 | 0 | $0 |
| Heather Ann Mcsharry | — | 5 अगस्त 2026 A | 20054 | 0 | 0 | $0 |
| Seamus Mulligan | — | 5 अगस्त 2026 A | 1184633 | 0 | 0 | $0 |
| Rick E Winningham | — | 5 अगस्त 2026 A | 11172 | 0 | 2 | $-1656873 |
| Patrick G. Enright | — | 5 अगस्त 2026 A | 22984 | 0 | 0 | $0 |
| Bruce C Cozadd | — | 5 अगस्त 2026 A | 362287 | 0 | 20 | $-25646326 |
| Ted W Love | — | 5 अगस्त 2026 A | 3132 | 0 | 0 | $0 |
| Norbert G Riedel | — | 5 अगस्त 2026 A | 8629 | 0 | 1 | $-655680 |
| Kenneth W O'Keefe | — | 2 दिसमबर 2025 F | 25811 | 0 | 0 | $0 |
| Daniel N Swisher JR | — | 3 जनवरी 2019 F | 16512 | 0 | 0 | $0 |
| Suzanne Sawochka Hooper | — | 14 दिसमबर 2018 M | 41184 | 0 | 0 | $0 |
| Matthew P. Young | — | 23 नवमबर 2018 S | 32068 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | — | 13 नवमबर 2018 S | 24972 | 0 | 0 | $0 |
| Paul Treacy | — | 10 अगस्त 2018 S | 17458 | 0 | 0 | $0 |
| Elmar Schnee | — | 9 अगस्त 2018 A | 6094 | 0 | 0 | $0 |
| Peter Gray | — | 9 अगस्त 2018 A | 8182 | 0 | 0 | $0 |
| Catherine A. Sohn | — | 9 अगस्त 2018 A | 7654 | 0 | 0 | $0 |
| Paul L Berns | — | 9 अगस्त 2018 A | 6772 | 0 | 0 | $0 |
| Karen J Wilson | — | 11 मई 2018 S | 15757 | 0 | 0 | $0 |
| Karen L. Smith | — | 5 मार्च 2018 F | 28474 | 0 | 0 | $0 |
| Iain Mcgill | — | 5 मार्च 2018 F | 22048 | 0 | 0 | $0 |
| Russell J. Cox | — | 6 मार्च 2017 F | 52795 | 0 | 0 | $0 |
| Jeffrey K Tobias | — | 5 मार्च 2015 F | 38484 | 0 | 0 | $0 |
| Fintan Keegan | — | 8 जुलाई 2014 M | 31750 | 0 | 0 | $0 |
| Kathryn E Falberg | — | 5 मार्च 2014 F | 133387 | 0 | 0 | $0 |
| James C Momtazee | — | 13 अगस्त 2013 S | 17315 | 0 | 0 | $0 |
| Carol A Gamble | — | 9 मार्च 2012 S | 32213 | 0 | 0 | $0 |
| Alan Sebulsky | — | 9 मार्च 2012 S | 54355 | 0 | 0 | $0 |
| Samuel D Colella | — | 11 जनवरी 2012 M | 38347 | 0 | 0 | $0 |
| Michael W Michelson | — | 11 जनवरी 2012 M | 13885 | 0 | 0 | $0 |
| Mark G. Eller | — | 13 अगस्त 2011 M | 4151 | 0 | 0 | $0 |
| Michael A. Desjardin | — | 13 अगस्त 2011 M | 14574 | 0 | 0 | $0 |
| Janne Lt Wissel | — | 31 मई 2011 J | 48544 | 0 | 0 | $0 |
| Joan Colligan | — | 30 नवमबर 2010 J | 14424 | 0 | 0 | $0 |
| Robert M Myers | — | 30 नवमबर 2010 J | 156898 | 0 | 0 | $0 |
| James B Tananbaum | — | 25 अगस्त 2010 A | 21366 | 0 | 0 | $0 |
| Samuel R Saks | — | 21 जनवरी 2009 A | 358868 | 0 | 0 | $0 |
| Matthew K Fust | — | 28 नवमबर 2008 J | 58948 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 6 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Public Limited Company, Jazz Financing I Limited, Jazz Investments II Limited, Jazz Pharmaceuticals Italy S.p.A. ×4 फाइलिंग | 20 जून 2014 | — | प्रारंभिक फाइलिंग | — | SEC |
| KKR JP LLC, KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, KKR JP III LLC, KKR Partners III, L.P., KKR III GP LLC, Henry R. Kravis, George R. Roberts ×3 फाइलिंग | 12 मार्च 2013 | — | प्रारंभिक फाइलिंग | — | SEC |
| Longitude Capital Partners, LLC, Longitude Venture Partners, L.P., Longitude Capital Associates, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×3 फाइलिंग | 14 मार्च 2012 | — | प्रारंभिक फाइलिंग | — | SEC |
| Longitude Capital Partners, LLC (2), Longitude Venture Partners, L.P. (2), Longitude Capital Associates, L.P. (2), Patrick G. Enright (2), Juliet Tammenoms Bakker (2) ×3 फाइलिंग | 30 सितमबर 2011 | — | प्रारंभिक फाइलिंग | — | SEC |
| Azur Pharma Limited | 28 सितमबर 2011 | — | प्रारंभिक फाइलिंग | — | SEC |
| Jazz Pharmaceuticals, Inc., KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Partners III, L.P., KKR III GP LLC, KKR JP LLC, KKR JP III LLC | 28 अप्रैल 2005 | — | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 72 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IHE · iShares Trust | 3.55% | 224123 SH | 8 अगस्त 2026 | दैनिक |
| PJP · Invesco Exchange-Traded Fund Trust | 2.75% | 54246 SH | 8 अगस्त 2026 | दैनिक |
| PTH · Invesco Exchange-Traded Fund Trust | 1.88% | 18101 SH | 8 अगस्त 2026 | दैनिक |
| PILL · Direxion Shares ETF Trust | 1.47% | 931 NS | 30 अप्रैल 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1.10% | 3412 SH | 8 अगस्त 2026 | दैनिक |
| RFG · Invesco Exchange-Traded Fund Trust | 1.01% | 14167 SH | 8 अगस्त 2026 | दैनिक |
| IJK · iShares Trust | 0.86% | 367117 SH | 8 अगस्त 2026 | दैनिक |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.79% | 61910 SH | 8 अगस्त 2026 | दैनिक |
| PDP · Invesco Exchange-Traded Fund Trust | 0.64% | 37430 SH | 8 अगस्त 2026 | दैनिक |
| XJH · iShares Trust | 0.51% | 8479 SH | 8 अगस्त 2026 | दैनिक |
| ISCV · iShares Trust | 0.50% | 13756 SH | 8 अगस्त 2026 | दैनिक |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.50% | 14803 NS | 30 अप्रैल 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0.49% | 12809 NS | 31 मई 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.48% | 8322 SH | 8 अगस्त 2026 | दैनिक |
| IJH · iShares Trust | 0.44% | 2164793 SH | 8 अगस्त 2026 | दैनिक |
| SMMV · iShares Trust | 0.41% | 4673 SH | 8 अगस्त 2026 | दैनिक |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.41% | 101353 SH | 8 अगस्त 2026 | दैनिक |
| VFVA · VANGUARD WELLINGTON FUND | 0.32% | 11363 SH | 8 अगस्त 2026 | दैनिक |
| VBR · VANGUARD INDEX FUNDS | 0.31% | 867777 SH | 8 अगस्त 2026 | दैनिक |
| AVLV · AMERICAN CENTURY ETF TRUST | 0.28% | 154718 NS | 31 मई 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.28% | 8083 SH | 8 अगस्त 2026 | दैनिक |
| IYH · iShares Trust | 0.25% | 35721 SH | 8 अगस्त 2026 | दैनिक |
| ISCB · iShares Trust | 0.25% | 2794 SH | 8 अगस्त 2026 | दैनिक |
| DFAS · Dimensional ETF Trust | 0.25% | 169973 NS | 30 अप्रैल 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.24% | 1006 NS | 30 अप्रैल 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.24% | 19561 SH | 8 अगस्त 2026 | दैनिक |
| NUSC · Nushares ETF Trust | 0.23% | 14796 NS | 30 अप्रैल 2026 | N-PORT |
| ESML · iShares Trust | 0.23% | 25562 SH | 8 अगस्त 2026 | दैनिक |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.20% | 3508 NS | 31 मई 2026 | N-PORT |
| SMMD · iShares Trust | 0.20% | 29882 SH | 8 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.20% | 166548 SH | 8 अगस्त 2026 | दैनिक |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.20% | 10307 SH | 8 अगस्त 2026 | दैनिक |
| VXF · VANGUARD INDEX FUNDS | 0.17% | 719903 SH | 8 अगस्त 2026 | दैनिक |
| VB · VANGUARD INDEX FUNDS | 0.17% | 1366973 SH | 8 अगस्त 2026 | दैनिक |
| DFAT · Dimensional ETF Trust | 0.17% | 113983 NS | 30 अप्रैल 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.16% | 59597 NS | 30 अप्रैल 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.15% | 1679 NS | 31 मई 2026 | N-PORT |
| IWS · iShares Trust | 0.15% | 89654 SH | 8 अगस्त 2026 | दैनिक |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.14% | 59 NS | 31 मई 2026 | N-PORT |
| WSML · iShares Trust | 0.13% | 3473 SH | 8 अगस्त 2026 | दैनिक |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.13% | 2492 NS | 31 मई 2026 | N-PORT |
| IWR · iShares Trust | 0.11% | 243081 SH | 8 अगस्त 2026 | दैनिक |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 3276 SH | 8 अगस्त 2026 | दैनिक |
| XT · iShares Trust | 0.09% | 13696 SH | 8 अगस्त 2026 | दैनिक |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.08% | 4239 NS | 31 मई 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.08% | 42911 NS | 31 मई 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.07% | 2294 NS | 31 मई 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.07% | 147813 NS | 30 अप्रैल 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.06% | 45962 NS | 30 अप्रैल 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.05% | 7081 NS | 30 अप्रैल 2026 | N-PORT |